Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Philippines flag Philippines · Delayed Price · Currency is PHP
1.030
+0.020 (1.98%)
At close: Apr 28, 2026
17.05%
Market Cap 4.24B
Revenue (ttm) 6.87B
Net Income (ttm) 470.30M
Shares Out 4.11B
EPS (ttm) 0.11
PE Ratio 9.36
Forward PE n/a
Dividend 0.07 (6.93%)
Ex-Dividend Date Nov 13, 2025
Volume 18,000
Average Volume 19,900
Open 1.030
Previous Close 1.010
Day's Range 1.030 - 1.030
52-Week Range 0.720 - 1.100
Beta 0.24
RSI 53.20
Earnings Date Apr 30, 2026

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1988
Employees 1,811
Stock Exchange Philippine Stock Exchange
Ticker Symbol EURO
Full Company Profile

Financial Performance

In 2025, PSE:EURO's revenue was 6.87 billion, an increase of 18.50% compared to the previous year's 5.80 billion. Earnings were 470.30 million, an increase of 39.27%.

Financial Statements

News

There is no news available yet.